Improving the outcomes of children with cancer

Press Office

Susanne Barkmann

Phone+49 (0)40-426051212
Mobile+49 (0)173-6276993


The infiltration of tumor infiltrating lymphocytes (TILS) into a tumor allows statements on the immune response as well as prognoses on therapy success and survival outcomes. In order to make this biomarker more useful for childhood brain tumors, a practical technique that is oriented towards diagnostic routine has been lacking until now. With DIMEimmune, Professor Schüller's research team has now developed an analysis tool that can be applied to DNA methylation data and derive statements about...

The Research Institute Children's Cancer Center Hamburg was founded 15 years ago with the goal of better understanding the molecular basis of childhood cancer development and paving the way for new therapies. Today, around 50 employees, physicians, scientists and technical assistants work in the field of stem cell transplantation and immunotherapy, leukemias as well as pediatric neuro-oncology - in other words, they conduct research on topics that play a central role in pediatric oncology. The...

Interview mit Hirntumorforscher Professor Dr. Ulrich Schüller anlässlich des Welthirntumortags am 8. Juni 2021

Juli-Harnack-scholarship for medical postgraduate students in the field of pediatric onkology

New insights into the development of ALL - the most common type of cancer in childhood.

Clinically and molecularly distinct subgroup discovered within the group of atypical teratoid / rhabdoid tumors

Research institute becomes part of the national cancer initiative of the BmBF / BmfG

What are the special challenges in the area of research, therapy and long-term effects? What does the diagnosis mean for affected families? In the current readout of the member magazine DER SCHMETTERLING, the Fördergemeinschaft Kinderkrebs-Zentrum Hamburg e.V. . presents our current research in the field of child brain tumors. The new edition is available for download.